Heparin-induced thrombocytopenia diagnostic criteria

Heparin-induced thrombocytopenia
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Heparin-induced thrombocytopenia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
Echocardiography and Ultrasound
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Heparin-induced thrombocytopenia diagnostic criteria On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Heparin-induced thrombocytopenia diagnostic criteria All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Heparin-induced thrombocytopenia diagnostic criteria
CDC on Heparin-induced thrombocytopenia diagnostic criteria
Heparin-induced thrombocytopenia diagnostic criteria in the news
Blogs on Heparin-induced thrombocytopenia diagnostic criteria
Directions to Hospitals Treating Heparin-induced thrombocytopenia
Risk calculators and risk factors for Heparin-induced thrombocytopenia diagnostic criteria

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Shyam Patel [2]

Diagnostic Criteria

The 4T score

The current diagnostic algorithm for HIT involves calculation of the pre-test probability using the 4T score. This scoring system is used when a patient is found to have thrombocytopenia or thrombosis after heparin exposure. It is calculated before the heparin-PF4 IgG antibody is ordered, and it offers a cost-effective and efficient way for determining the likelihood of HIT.

• Thrmobocytopenia: 2 points are assigned to platelet count fall greater than 50% and platelet nadir greater than 20,000 per microliter. 1 point is assigned to platelet count fall 30-50% or platelet nadir 10,000-19,000 per microliter. No points are assigned to platelet count fall less than 30% or platelet nadir less than 10,000 per microliter.
• Thrombosis: 2 points are assigned to new confirmed thrombosis or skin necrosis at injection sites or acute systemic reaction after IV heparin bolus. 1 point is assigned to progressive or recurrent skin lesions or suspected thrombosis (without proof of thrombosis. No points are assigned if there is no thrombosis.
• Timing: 2 points are assigned if the platelet count fall clearly occurs between days 5 and 10, or if the platelet count fall occurs in less than 1 day if a patient had recent heparin exposure within the past 30 days. 1 point is assigned if the platelet count is likely to have fallen between days 5-10 (there may be missing platelet count checks), or platelet count fall after day 10, or platelet count fall within 1 day in the setting of prior heparin exposure 30-100 days ago. No points are assigned if platelet count fall occurs within 4 days in the setting of no heparin exposure.
• oTher: 2 points are assigned if there is no apparent alternative explanation of thrombocytopenia. 1 point is assigned if there is a possible alternative explanation of thrombocytopenia. No points are assigned if there is a definite alternative explanation of thrombocytopenia.

• 0 to 3 points: low probability
• 4 to 5 points: intermediate probability
• 6 to 8 points: high probability

The American Society of Hematology, as part of the Choosing Wisely program, states:

"Don’t test or treat for suspected heparin-induced thrombocytopenia (HIT) in patients with a low pre-test probability of HIT."